“[Complementary Strategy of RSVpreF Vaccination/Nirsevimab versus Nirsevimab Alone for the Prevention of RSV Infection in Infants in Italy: A Cost-Minimization Analysis]”, FE, vol. 26, no. 1, Jul. 2025, doi: 10.7175/fe.v26i1.1583.